• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.94 Down 0.04(0.67%) Dec 26, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 3,428   3,428   4,399  
    Cost of Revenue -   -   -  
    Gross Profit 3,428   3,428   4,399  
    Operating Expenses
    Research Development56,748  73,680  12,780  
    Selling General and Administrative23,878  19,987  19,502  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (77,198) (90,239) (27,883)
    Income from Continuing Operations
    Total Other Income/Expenses Net65  147  46  
    Earnings Before Interest And Taxes(77,133)(90,092)(27,837)
    Interest Expense538  2  221  
    Income Before Tax(77,671)(90,094)(28,058)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(77,671)(90,094)(28,058)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (77,671) (90,094) (28,058)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (77,671) (90,094) (28,058)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.